[
    "{\"step_by_step_thinking\": \"Duchenne muscular dystrophy is a genetic disorder characterized by progressive muscle degeneration and weakness. Both deflazacort and prednisone/prednisolone are corticosteroids used in the treatment of this condition. The efficiency of these drugs can be measured by their ability to slow the progression of muscle weakness and improve muscle strength. According to several studies, deflazacort has shown to delay the progression of Duchenne muscular dystrophy more effectively than prednisone/prednisolone. However, it's important to note that the choice of medication can depend on individual patient factors, including side effect profiles and patient tolerance.\", \"answer_choice\": \"A\"}"
]